Eli Lilly and Company News - July 7, 2026

Lilly's Double Catalyst — Can a $50 Obesity Pill and a Cancer Drug Expansion Justify a Trillion-Dollar Valuation?

Shares of Eli Lilly surged 3.7% to $1,244.16 after two developments landed in quick succession: European regulators endorsed a broader use for the company's...

🟢 LLY is trading 3.7% up today after Medicare pricing deal and Jaypirca label expansion

LLY is trading 3.7% up at $1244.16 following positive regulatory and reimbursement developments for its core drug portfolio. • An EMA panel recommended a...